Format
Sort by
Items per page

Send to

Choose Destination

Best matches for methylselenocysteine prostate:

Search results

Items: 1 to 20 of 32

1.

Selenomethionine and methyl selenocysteine: multiple-dose pharmacokinetics in selenium-replete men.

Marshall JR, Burk RF, Payne Ondracek R, Hill KE, Perloff M, Davis W, Pili R, George S, Bergan R.

Oncotarget. 2017 Apr 18;8(16):26312-26322. doi: 10.18632/oncotarget.15460.

2.

Se-methylselenocysteine suppresses the growth of prostate cancer cell DU145 through connexin 43-induced apoptosis.

Lu Z, Qi L, Li GX, Bo XJ, Liu GD, Wang JM.

J Cancer Res Ther. 2015 Oct-Dec;11(4):840-5. doi: 10.4103/0973-1482.139265.

3.

Prenatal exposure to soy and selenium reduces prostate cancer risk factors in TRAMP mice more than exposure beginning at six weeks.

Nakken HL, Lephart ED, Hopkins TJ, Shaw B, Urie PM, Christensen MJ.

Prostate. 2016 May;76(6):588-96. doi: 10.1002/pros.23150. Epub 2016 Jan 28.

PMID:
26817824
4.

Sleep interruption associated with house staff work schedules alters circadian gene expression.

Fang MZ, Ohman-Strickland P, Kelly-McNeil K, Kipen H, Crabtree BF, Lew JP, Zarbl H.

Sleep Med. 2015 Nov;16(11):1388-1394. doi: 10.1016/j.sleep.2015.06.011. Epub 2015 Jul 23.

5.

Methylselenocysteine preventing castration-resistant progression of prostate cancer.

Liu Y, Liu X, Guo Y, Liang Z, Tian Y, Lu L, Zhao X, Sun Y, Zhao X, Zhang H, Dong Y.

Prostate. 2015 Jun 15;75(9):1001-8. doi: 10.1002/pros.22987. Epub 2015 Mar 8.

6.

Methylseleninic acid elevates REDD1 and inhibits prostate cancer cell growth despite AKT activation and mTOR dysregulation in hypoxia.

Sinha I, Allen JE, Pinto JT, Sinha R.

Cancer Med. 2014 Apr;3(2):252-64. doi: 10.1002/cam4.198. Epub 2014 Feb 7.

7.

Selenium Biomarkers in Prostate Cancer Cell Lines and Influence of Selenium on Invasive Potential of PC3 Cells.

Hendrickx W, Decock J, Mulholland F, Bao Y, Fairweather-Tait S.

Front Oncol. 2013 Sep 23;3:239. doi: 10.3389/fonc.2013.00239. eCollection 2013.

8.

Methylselenol prodrug enhances MDV3100 efficacy for treatment of castration-resistant prostate cancer.

Zhan Y, Cao B, Qi Y, Liu S, Zhang Q, Zhou W, Xu D, Lu H, Sartor O, Kong W, Zhang H, Dong Y.

Int J Cancer. 2013 Nov;133(9):2225-33. doi: 10.1002/ijc.28202. Epub 2013 May 9.

9.

Combination effects of dietary soy and methylselenocysteine in a mouse model of prostate cancer.

Christensen MJ, Quiner TE, Nakken HL, Lephart ED, Eggett DL, Urie PM.

Prostate. 2013 Jun;73(9):986-95. doi: 10.1002/pros.22646. Epub 2013 Feb 6.

10.

Nutritional and supranutritional levels of selenate differentially suppress prostate tumor growth in adult but not young nude mice.

Holmstrom A, Wu RT, Zeng H, Lei KY, Cheng WH.

J Nutr Biochem. 2012 Sep;23(9):1086-91. doi: 10.1016/j.jnutbio.2011.06.001. Epub 2011 Dec 1.

PMID:
22137259
11.

Soy content of basal diets determines the effects of supplemental selenium in male mice.

Quiner TE, Nakken HL, Mason BA, Lephart ED, Hancock CR, Christensen MJ.

J Nutr. 2011 Dec;141(12):2159-65. doi: 10.3945/jn.111.146498. Epub 2011 Oct 26.

12.

Methyl selenocysteine: single-dose pharmacokinetics in men.

Marshall JR, Ip C, Romano K, Fetterly G, Fakih M, Jovanovic B, Perloff M, Crowell J, Davis W, French-Christy R, Dew A, Coomes M, Bergan R.

Cancer Prev Res (Phila). 2011 Nov;4(11):1938-44. doi: 10.1158/1940-6207.CAPR-10-0259. Epub 2011 Aug 16.

13.

Mouse prostate proteomes are differentially altered by supranutritional intake of four selenium compounds.

Zhang J, Wang L, Li G, Anderson LB, Xu Y, Witthuhn B, Lü J.

Nutr Cancer. 2011;63(5):778-89. doi: 10.1080/01635581.2011.563029. Epub 2011 Jun 1.

PMID:
21614726
14.

Lobe-specific lineages of carcinogenesis in the transgenic adenocarcinoma of mouse prostate and their responses to chemopreventive selenium.

Wang L, Zhang J, Zhang Y, Nkhata K, Quealy E, Liao JD, Cleary MP, Lü J.

Prostate. 2011 Sep 15;71(13):1429-40. doi: 10.1002/pros.21360. Epub 2011 Feb 25.

PMID:
21360561
15.

Investigation of the selenium metabolism in cancer cell lines.

Lunøe K, Gabel-Jensen C, Stürup S, Andresen L, Skov S, Gammelgaard B.

Metallomics. 2011 Feb;3(2):162-8. doi: 10.1039/c0mt00091d. Epub 2010 Dec 16.

PMID:
21161099
16.

Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.

Liu X, Gao R, Dong Y, Gao L, Zhao Y, Zhao L, Zhao X, Zhang H.

BMC Cancer. 2010 Aug 10;10:418. doi: 10.1186/1471-2407-10-418.

17.

Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model.

Zhang J, Wang L, Anderson LB, Witthuhn B, Xu Y, Lü J.

Cancer Prev Res (Phila). 2010 Aug;3(8):994-1006. doi: 10.1158/1940-6207.CAPR-09-0261. Epub 2010 Jul 20.

18.

Selenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors.

Lindshield BL, Ford NA, Canene-Adams K, Diamond AM, Wallig MA, Erdman JW Jr.

PLoS One. 2010 Apr 29;5(4):e10423. doi: 10.1371/journal.pone.0010423.

19.

Alpha-keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells.

Nian H, Bisson WH, Dashwood WM, Pinto JT, Dashwood RH.

Carcinogenesis. 2009 Aug;30(8):1416-23. doi: 10.1093/carcin/bgp147. Epub 2009 Jun 15.

20.

Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit.

Wang L, Bonorden MJ, Li GX, Lee HJ, Hu H, Zhang Y, Liao JD, Cleary MP, Lü J.

Cancer Prev Res (Phila). 2009 May;2(5):484-95. doi: 10.1158/1940-6207.CAPR-08-0173. Epub 2009 Apr 28.

Supplemental Content

Loading ...
Support Center